By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cipla Ltd. 

Mumbai Central

Mumbai    400 008  India
Phone: 91-22-308-2891-or-91-22-309-5521 Fax: 91-22-307-0013



Company News
Big Pharmas Like Cipla (CIPLA), Pfizer (PFE) Among the 200 Under Inspection for Poor Drugs 6/21/2016 7:15:04 AM
Sources Reveal Glenmark Pharma, Sun Pharma (SUNPHARMA.NS), Cipla (CIPLA) are Exploring Bids Worth $500-800 Million for Teva (TEVA)'s Generics Products Portfolio 11/19/2015 6:54:02 AM
Cipla (CIPLA) Sells Stake In China's Biomab For $25 Million 10/30/2015 11:54:44 AM
Indian Drugmakers Like Cipla (CIPLA) and BDR Pharma Work on Hepatitis C Cocktails Impossible in the U.S. 10/12/2015 6:43:18 AM
Cipla (CIPLA) Strikes $550 Million Deal to Acquire Two U.S. Drugmakers 9/4/2015 6:00:21 AM
Cipla Executives Resigning, But Company Says Nothing Amiss 6/19/2015 6:14:57 AM
Cipla, Lupin (LUPN.BO) Make Bid for UCB SA’s $1 Billion Generics Unit 6/1/2015 6:22:27 AM
Cipla Ltd. Sells Stake In Jiangsu Cdymax Pharma For $18.5 Million 12/12/2014 10:27:48 AM
Meda And Cipla Ltd. Sue Apotex Corp. To Enforce Dymista® Patents 12/3/2014 9:06:22 AM
Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG (NVS) 10/30/2014 6:26:21 AM